kynurenine has been researched along with zoledronic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campia, I; Gazzano, E; Ghigo, D; Kopecka, J; Orecchia, S; Riganti, C; Salaroglio, IC | 1 |
1 other study(ies) available for kynurenine and zoledronic acid
Article | Year |
---|---|
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.
Topics: Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Cell Proliferation; Cells, Cultured; Cholesterol; Diphosphonates; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes; Terpenes; Tumor Cells, Cultured; Zoledronic Acid | 2015 |